Reckitt Benckiser will pay 32.6 billion rupees ($726 million) for private equity-backed Paras Pharmaceuticals, Reuters reported. Buyout shop Actis owns 63% of India’s Paras. Other shareholders include Silicon Valley-based venture firm Sequoia Capital. UK-based Reckitt Benckiser produces a wide range of household, health and personal care products.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
